Literature DB >> 12130922

Dyspnea: the continuing challenge of palliative management.

Susan B LeGrand1.   

Abstract

The management of dyspnea is a challenge even for the most experienced palliative medicine teams. In the absence of effective treatment for the underlying disease, therapeutic options are limited to the supplementation of oxygen, the use of opioids, and multidisciplinary nonpharmacologic interventions. There is increased research into both the physiology of dyspnea and the correlates of the symptom in advanced disease. Hopefully, this research will lead to improved therapy in the future. This article reviews current literature on dyspnea with a focus on publications in 2001.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130922     DOI: 10.1097/00001622-200207000-00004

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  4 in total

1.  Dyspnoea associated with anxiety--symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients.

Authors:  Katri Elina Clemens; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2010-12-14       Impact factor: 3.603

2.  The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer.

Authors:  Digant Gupta; Christopher G Lis; James F Grutsch
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

3.  Physical therapy in palliative care: from symptom control to quality of life: a critical review.

Authors:  Senthil P Kumar; Anand Jim
Journal:  Indian J Palliat Care       Date:  2010-09

4.  A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.

Authors:  S H Ahmedzai; E Laude; A Robertson; G Troy; V Vora
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.